Chemours (CC) Operating Expenses (2014 - 2026)

Chemours has reported Operating Expenses for 13 years, with the latest figure at $186.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 1.64% year-over-year to $186.0 million; the trailing twelve-month figure through Mar 2026 stood at $969.0 million (up 15.77% YoY), and the FY2025 full-year result was $966.0 million, up 17.38% from the prior year.
• Operating Expenses for Q1 2026 stood at $186.0 million, up from $161.0 million in the prior quarter.
• The five-year high for Operating Expenses was $806.0 million in Q2 2023, with the low at $152.0 million in Q3 2025.
• Average Operating Expenses over 5 years is $256.9 million, with a median of $186.0 million recorded in 2026.
• Year-over-year, Operating Expenses jumped 187.86% in 2023 and slumped 77.3% in 2024.
• Tracing CC's Operating Expenses over 5 years: stood at $211.0 million in 2022, then rose by 21.8% to $257.0 million in 2023, then retreated by 20.62% to $204.0 million in 2024, then fell by 21.08% to $161.0 million in 2025, then climbed by 15.53% to $186.0 million in 2026.
• The last three Operating Expenses figures came in at $186.0 million (Q1 2026), $161.0 million (Q4 2025), and $152.0 million (Q3 2025), per Business Quant data.

Peer Comparison